These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21295437)

  • 1. [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009].
    Ndondoki C; Dabis F; Namale L; Becquet R; Ekouevi D; Bosse-Amani C; Arrivé E; Leroy V
    Presse Med; 2011; 40(7-8):e338-57. PubMed ID: 21295437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
    Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
    BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
    Walker AS; Mulenga V; Ford D; Kabamba D; Sinyinza F; Kankasa C; Chintu C; Gibb DM;
    Clin Infect Dis; 2007 May; 44(10):1361-7. PubMed ID: 17443476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.
    Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ
    Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
    Mulenga V; Ford D; Walker AS; Mwenya D; Mwansa J; Sinyinza F; Lishimpi K; Nunn A; Gillespie S; Zumla A; Chintu C; Gibb DM;
    AIDS; 2007 Jan; 21(1):77-84. PubMed ID: 17148971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis.
    Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee
    AIDS; 2008 Jan; 22(1):97-105. PubMed ID: 18090397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
    Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
    N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.
    Suthar AB; Granich R; Mermin J; Van Rie A
    Bull World Health Organ; 2012 Feb; 90(2):128C-138C. PubMed ID: 22423164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler GH
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.
    Cheng W; Wu Y; Wen Y; Ma Y; Zhao D; Dou Z; Zhang W; Bulterys M; Zhang F
    Bull World Health Organ; 2015 Mar; 93(3):152-60. PubMed ID: 25838611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
    Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
    N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
    Humphreys EH; Smith NA; Azman H; McLeod D; Rutherford GW
    Cochrane Database Syst Rev; 2010 Jun; (6):CD008563. PubMed ID: 20556793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
    Grimwade K; Swingler ; G
    Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
    Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
    J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler G
    Cochrane Database Syst Rev; 2003; (2):CD003508. PubMed ID: 12804472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa.
    Grimwade K; Sturm AW; Nunn AJ; Mbatha D; Zungu D; Gilks CF
    AIDS; 2005 Jan; 19(2):163-8. PubMed ID: 15668541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.